Filing Details
- Accession Number:
- 0000950170-25-081715
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-04 17:00:15
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-04
- Accepted Time:
- 2025-06-04 17:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1493056 | Preston Klassen | C/O Regulus Therapeutics Inc. 4224 Campus Point Ct., #210 San Diego CA 92121 | President & Head Of R & D | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-03 | 12,000 | $7.99 | 48,055 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
